WEEK 3 AND 4 Flashcards

1
Q

what is CAUSALITY?
Best study design
Challenges

A

 ‘Makes happen’
 Its presence directly impacts, changes or effects something else
 It is upstream
 Often we are interested in causality
 But it can be very difficult to ‘prove’ a cause and effect relationship
 RCTs can help assess causality, but have limitations too
 Different methodological approaches may be superior

“Both practical and ethical considerations mean that causality cannot, in general, be proved in human
studies. Rather, it must be induced from demonstrated associations between and exposure and health
outcomes.
Characteristics of that association, judged against some framework, then help to assess whether that
association is or is not causal”

How can we decide if a risk factors causes a disease?
Build up a solid body of evidence
Use a checklist that helps us decide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

BRADFORD HILL CRITERIA

A

Useful to help establish the strength of epidemiological evidence of a causal relationship
But, they are not criteria that must be fulfilled
Instead provide ways of examining whether cause and effect is a reasonable inference

  1. Temporal relationship (essential)
    For a risk factor to cause a disease it must occur/be present before the disease
  2. Strength (effect size)
    A strong association is more likely to be causal (but the reverse is NOT true)
  3. Consistency (reproducibility)
    Similar results are obtained in different populations with different study designs (given their varying
    combinations of other ‘chance’ factors)
  4. Analogy
    Similarities with other well-established cause-effect relationships
  5. Specificity
    The more specific an association between a factor and an effect, the increased probability of a causal
    association
    Rarely occurs, as most diseases have multiple causes and most exposures, multiple effects
    e.g. Huntington’s disease caused by a defect in a specific gene
  6. Reversibility
    If the removal of a possible risk factor results in reduced risk of disease, then the likelihood that the
    association is causal is increased.
  7. Dose-response relationship
    Helpful to assist in confidence around causality, but not essential
  8. Plausibility
    Must be consistent with knowledge from other sources (e.g. animal experiments) & should make
    biological sense
  9. Coherence
    The suggested cause-effect should be consistent with the natural history and biology of the disease
    and should not conflict with the generally known facts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

CAUSALITY- CHALLENGE FOR EPIDEMIOLOGISTS

A

Whether links between exposures and outcomes/disease can be considered causal can only
be assessed with confidence once full consideration has been taken of other factors

 The notion of cause has become more complex
 Most health outcomes having multiple component causes
 Distinguishing which of these are necessary or sufficient is central to preventive efforts
 How far upstream should the matter of cause (& thus potential intervention) be pursued

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

EXTERNAL VALIDITY

A

The degree to which the study findings can be applied to individuals not in the study
Two underlying concepts:
1. Generalisability
To what extent does the study sample represent the target population
2. Applicability
Whether the results of the study can be applied to a particular sample within the population
(clinical and psychosocial factors, health status)

Applicability refers to whether or not the study can be applied to your specific clinical setting and individual patient

 A research finding may be entirely valid in one setting but not another

relates to the extent to which the results are likely to impact on practice”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

INTERNAL VALIDITY
Extent to which…

A

Degree to which the investigator draws the correct conclusion about what actually happened in
the study
Extent to which the design and conduct of the trial/study, & methods used for analysis:
 eliminate the possibility of bias (50+ types)
 minimise impact of other factors (confounding, interaction)
 reduce likelihood of random errors & chance findings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Internal vs external validity diagram

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

BIAS
Selection
Information

A

A systematic error in the design, recruitment, data collection or analysis that results in a mistaken
estimation of the true effect of the exposure and outcome
1. Selection bias: systematic error in the selection or retention of participants
2. Information (misclassification) bias: systematic error due to inaccurate measurement or
classification of disease, exposure or other variables
Bias limits validity of study results & is rarely eliminated during analysis
Thus, KEY is the study design and methods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How to judge external validity?

A

 Often there are inclusion or exclusion criteria for a study e.g age, health, availability
 Regardless of these criteria, the recruited sample can never be 100% representative
 Individuals agreeing to participate in research studies are different from those who don’t
 A matter of judgment
 Age, sex, severity of disease, comorbid conditions
 Similar drugs, other doses, timing, route of administration
 Other outcomes (not assessed), different duration of treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

SELECTION BIAS IN CASE CONTROL STUDIES

A

 Inherent in the design, resulting in non-comparability between cases & controls
 Cases & controls drawn from different populations
 Particularly problematic in hospital settings
e.g.
Cases: A hospital-based study will fail to enrol severe cases that die before reaching hospital;
Cases not representative of all cases in the population
Controls: Study of the effects of smoking on lung cancer.
Controls may be selected from individuals hospitalised on respiratory ward for other conditions,
which may also be related to smoking
Over-representation of smoking in the control group would under-estimate the association

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

SELECTION BIAS IN COHORT STUDIES
When it can occur?

A

Less problematic because exposure status identified prior to outcome occurring
Can occur when non-response rate / loss to follow-up differs between exposure groups
E.g. A study investigating the role of heavy alcohol consumption on disease A
* Heavy drinkers may be less likely to respond (non-response related to exposure)
* People with a family history of disease A may be more likely to participate (non-response related
to disease)
* The cohort prevalence and incidence rates will be different from the general population
* The measured association between alcohol and disease A may also be biased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

SELECTION BIAS IN RCTS

A

Less likely if: randomisation performed correctly, sufficiently large sample
Blinding to treatment allocation is important

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

INFORMATION BIAS,,
What is
Difference between Non-differential vs Differential

A

 Systematic errors due to inaccurate measurement or classification
1. Non-differential classification
 Misclassification is random (all individuals have same probability of being misclassified)
2. Differential classification
 Misclassification of disease status is dependent upon risk factor status (or vice-versa)
Includes instrumentation errors, misdiagnosis, and missing data, also…

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

INFORMATION BIAS, observer, interviewer, reporting, recall

A

 Observer bias: prior knowledge of expected outcome influences the way the information is
collected, measured or interpreted
 Interviewer bias: leading questions which may systematically influence responses given
 Reporting bias: individuals may selectively suppress or reveal information
e.g. people living near telecommunication towers might report adverse effects because of
hypersensitivity about cancer threat
 Recall bias: when the information provided on exposure differs between exposed & unexposed
Particularly problematic in case-control & retrospective cohort studies
e.g. individuals with cancer may be more likely to recall exposure to toxic chemicals than controls

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

INFORMATION BIAS – HAWTHORNE EFFECT

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

REASONS FOR MISCLASSIFIED INFORMATION

A

Information bias- arise from the measurement error
 Poorly worded, ambiguous questions
 Instruments developed in one setting are not appropriate to another setting
 Incriminating or personal questions (e.g. IV drug use, sex-related)
 Multiple interviewers can lead to systematic errors in misclassification
 Self-reported, telephone and face-to-face survey can provide startlingly different results
 Blinding can reduce observer/interviewer bias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

REDUCING CHANCE FINDINGS

A

To minimise spurious “chance” findings
 Strong a priori rationale
 Plausible - having an appearance of truth or reason
 Adequate sample size
 Correct statistical analysis
 Replication of findings

17
Q

CONFOUNDING, EFFECT MODIFICATION (INTERACTION) & MEDIATION

A

> CONFOUNDER
 An extraneous variable that wholly or partially accounts for the observed effect of a risk factor
on disease status
 Masks the true effect of an exposure on an outcome (thus leads to inaccurate results)
EFFECT MODIFIER (interaction)
 A variable that differentially (positively or negatively) modifies the observed effect of a risk
factor on disease status
 The effect of an exposure on an outcome is different for different groups
>MEDIATOR
 On the ‘causal’ pathway between the exposure and outcome

18
Q

CONFOUNDING vs INTERACTION

A
  • Confounding and Interaction (effect modification) are NOT the same
     A confounder MUST be associated with both the exposure & outcome
     BUT, not on the causal pathway
     Impact: Can be over or under estimation of the ‘true’ association
19
Q

CONTROLLING FOR CONFOUNDING: at the design stage
3 different methods

A

 May be identified at design stage based on previous knowledge
 Randomisation: Ideal, as you can control for known & unknown factors. But only possible in
clinical trial
 Restriction: limits study participation to those with similar confounders (ie. including only non-
smokers avoids any confounding due to smoking). But then limits generalisability.
 Matching: of individuals in case and control group, so they are as similar as possible
(generally only in case-control studies). Pair & frequency matching. But, limits to degree of
matching & must be decided in advance

20
Q

CONTROLLING FOR CONFOUNDING: analysis stage

A

Stratification:
* Examine the association between exposure and outcome within different strata of the
confounding factor (e.g. separately in smokers & non-smokers). Resembles matching.
Multivariable analysis
* Statistical modelling to control for 1+ confounders.
* Most common method, very useful for cohort studies
 Residual confounding: can only ‘adjust’ for things we know about & have measured
– known knowns, not unknown unknowns

21
Q

INTERACTION / EFFECT MODIFICATION

A

When the association between exposure & outcome differs by a ‘level’ of another (3rd) factor
 The 3rd variable ‘modifies’ this relationship
 Exposure has a different effect on outcome in different subgroups
 Overall estimate of the association between exposure – outcome is misleading
E.g. The association between getting the flu and dying
 What factor could be an effect modifier?
Age, health status
 There is likely to be a stronger association in some individuals compared to others (elderly, infants, very
sick people)
 Much weaker association in other populations

22
Q

P-value

A

 Don’t base your conclusions solely on whether an association/effect was “statistically
significant” (e.g. passing an arbitrary threshold)
 Don’t believe an association/effect doesn’t exist just because it was not statistically significant
 Don’t conclude anything about importance or clinical relevance based on significance or lack
thereof

23
Q

Why do we want to do Qualitative Research?

A
24
Q

Importance of Qualitative Research

A

Qualitative research provides us with an
opportunity to explore:
* emerging patterns
* contradictions
* ambiguities
* unforeseen variables
* surprising findings
* new perspectives
* theories

Seeks to:
* Understand complex or poorly understood phenomena
* Explore a central phenomena
* Ask participants broad questions
* Explore the impact of social, cultural, political factors
on health and disease
* Examine the interactions and behaviours of individuals
and groups

25
Q

Qualitative vs quantitative

A
26
Q

Qualitative Research Designs (6)

A
27
Q

MIXED METHOD STUDY DESIGNS

A
28
Q

Descriptive research design

A
29
Q

Phenomenonlogy

A